Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. (Record no. 20773226)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02450 a2200709 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516033543.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201106s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1474-5488 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/S1470-2045(11)70081-X |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Moreau, Philippe |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20110628 |
245 00 - TITLE STATEMENT | |
Title | Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The Lancet. Oncology |
Date of publication, distribution, etc. | May 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 431-40 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Asia |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Cells |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Boronic Acids |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bortezomib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Administration Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Europe |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Infusions, Intravenous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Injections, Subcutaneous |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Multiple Myeloma |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Staging |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Peripheral Nervous System Diseases |
General subdivision | chemically induced |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protease Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrazines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recurrence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | South America |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pylypenko, Halyna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grosicki, Sebastian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karamanesht, Ievgenii |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leleu, Xavier |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grishunina, Maria |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rekhtman, Grigoriy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Masliak, Zvenyslava |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Robak, Tadeusz |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shubina, Anna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Arnulf, Bertrand |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kropff, Martin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cavet, James |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Esseltine, Dixie-Lee |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Feng, Huaibao |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Girgis, Suzette |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | van de Velde, Helgi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Deraedt, William |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Harousseau, Jean-Luc |
773 0# - HOST ITEM ENTRY | |
Title | The Lancet. Oncology |
Related parts | vol. 12 |
-- | no. 5 |
-- | p. 431-40 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/S1470-2045(11)70081-X">https://doi.org/10.1016/S1470-2045(11)70081-X</a> |
Public note | Available from publisher's website |
No items available.